Role of p38 mitogen-activated protein kinase in lung injury after burn trauma

Shock

Volumn 19, Issue 5, 2003, Pages 475-479

  Chen, Xu Lin ^a   Xia, Zhao Fan ^a   Ben, Dao Feng ^a   Wang, Guang Qing ^a   Wei, Duo ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Burns; Interleukin 1 ; Mitogen activated protein (MAP) kinase; p38; Tumor necrosis factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALBUMIN; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; RINGER SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SURFACE; BURN; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; LUNG CAPILLARY; LUNG INJURY; LUNG LAVAGE; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN SECRETION; RAT; WESTERN BLOTTING;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; BURNS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; IMIDAZOLES; INTERLEUKIN-1; LUNG; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PULMONARY CIRCULATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642468286     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000055242.25446.84     Document Type: Article

References (35)

1. Herndon DN, Barrow RE, Linares HA, Rutan RL, Prien T, Traber LD, Traber DL: Inhalation injury in burned patients: effects and treatment. Burns 14:349-356, 1988.
2. Schmid E, Piccolo MT, Friedl HP, Warner RL, Mulligan MS, Hugli TE, Till GO, Ward PA: Requirement for C5a in lung vascular injury following thermal trauma to rat skin. Shock 8:119-124, 1997.
3. Ryan CM, Schoenfield DA, Thorpe WP, Sheridan RL, Cassem EH, Thompkins RG: Objective estimates of the probability of death from burn injuries. N Engl J Med 338:362-366, 1998.
4. Hales CA, Elsasser TH, Ocampo P, Efimova O: TNF-alpha in smoke inhalation lung injury. J Appl Physiol 82:1433-1437, 1997.
5. Piccolo MT, Wang Y, Sannomiya P, Piccolo NS, Piccolo MS, Hugli TE, Ward PA, Till GO: Chemotactic mediator requirements in lung injury following skin burns in rats. Exp Mol Pathol 66:220-226, 1999.
6. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A: p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277:1531-1538, 1997.
7. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 273:934-941, 1995.
8. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269:1829-1835, 1993.
9. Yang J, Murphy C, Denham W, Botchkina G, Tracey KJ, Norman J: Evidence of a central role for p38 map kinase induction of tumor necrosis factor alpha in pancreatitis-associated pulmonary injury. Surgery 126:216-222, 1999.
10. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 29:628-634, 2001.
11. Ono K, Han J: The p38 signal transaction pathway: activation and function. Cell Signal 12:1-13, 2000.
12. Otani Y, Takeyoshi I, Koibuchi Y, Matsumoto K, Muramoto M, Morishita Y: The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. J Heart Lung Transplant 19:377-383, 2000.
13. Lin H, Gong X, Zhong J: Effect of glucocorticoid receptor blockade on pulmonary and renal vascular permeability in scalded rats. Chin J Plastic Surg Burn 11:103-105, 1995.
14. Gloor B, Blinman TA, Rigberg DA, Todd KE, Lane JS, Hines OJ, Reber HA: Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 21:414-420, 2000.
15. Magnotti LJ, Xu DZ, Lu Q, Deitch EA: Gut-derived mesenteric lymph: a link between bum and lung injury. Arch Surg 134:1333-1340, 1999.
16. Ballard-Croft C, White DJ, Maass DL, Hybki DP, Horton JW: Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-α. Am J Physiol Heart Circ Physiol 280:H1970-H1981, 2001.
17. Ballard-Croft C, Horton JW: Sympathoadrenal modulation of stress-activated signaling in bum trauma. J Burn Care Rehabil 23:172-182, 2002.
18. Tokyay R, Zeigler ST, Traver DL, Stothert JC Jr, Loick HM, Heggers JP, Herndon DN: Postburn gastrointestinal vasoconstriction increases bacterial and endotoxin translocation. J Appl Physiol 74:1521-1527, 1993.
19. Horton JW: Oxygen free radicals contribute to postburn cardiac cell membrane dysfunction. J Surg Res 61:97-102, 1996.
20. Szabo C, Thiemermann C: Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 2:145-155, 1994.
21. Kayyali US, Donaldson C, Huang H, Abdelnour R, Hassoun PM: Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem 276:14359-14365, 2001.
22. Loitsch SM, von Mallinckrodt C, Kippenberger S, Steinhilber D, Wagner TO, Bargon J: Reactive oxygen intermediates are involved in IL-8 production induced by hyperosmotic stress in human bronchial epithelial cells. Biochem Biophys Res Commun 276:571-578, 2000.
23. Arturson G: Pathophysiology of the bum wound and pharmacological treatment. The Rudi Hermans Lecture, 1995.Burns. Burns 22:255-274, 1996.
24. Kawashima Y, Takeyoshi I, Otani Y, Koibuchi Y, Yoshinari D, Koyama T, Kobayashi M, Matsumoto K, Morishita Y: FR167653 attenuates ischemia and reperfusion injury of the rat lung with suppressing p38 mitogen-activated protein kinase. J Heart Lung Transplant 20:568-574, 2001.
25. Kraatz J, Clair L, Rodriguez JL, West MA: In vitro macrophage endotoxin tolerance: defective in vitro macrophage map kinase signal transduction after LPS pretreatment is not present in macrophages from C3H/HeJ endotoxin resistant mice. Shock 11:58-63, 1999.
26. Adams JL, Badger AM, Kumar S, Lee JC: p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem 38:1-60, 2001.
27. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL, Griswold DE: Pharmacological profile of SB 203580, a selective inhibitor of CSBPrp38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461, 1996.
28. Arcaroli J, Yum HK, Kupfner J, Park JS, Yang KY, Abraham E: Role of p38 MAP kinase in the development of acute lung injury. Clin Immunol 101:211-219, 2001.
29. Eder J: Tumor necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol Sci 18:319-322, 1997.
30. O'Suilleabhain CB, Kim S, Rodrick MR, Mannick JA, Lederer JA: Injury induces alterations in T-cell NF kappaB and AP-1 activation. Shock 15:432-437, 2001.
31. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R: IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway. J Biol Chem 273:6607-6610, 1998.
32. Wang GQ, Xia ZF, Yu BJ, Xiao SC, Chen YL: Cardiac apoptosis in burned rats with delayed fluid resuscitation. Burns 27:250-253, 2001.
33. Horton JW, White DJ, Maass DL, Hybki DP, Haudek S, Giroir B: Antioxidant vitamin therapy alters bum trauma-mediated cardiac NF-kappaB activation and cardiomyocyte cytokine secretion. J Trauma 50:397-406, 2001.
34. Hua LL, Zhao ML, Cosenza M, Kim MO, Huang H, Tanowitz HB, Brosnan CF, Lee SC: Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFalpha expression in human fetal astrocytes. J Neuroimmunol 126:180-189, 2002.
35. Zhao TC, Taher MM, Valerie KC, Kukreja RC: p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS. Circ Res 89:915-922, 2001.